Retia Medical, a Valhalla, NY-based innovator in advanced hemodynamic monitoring, secured $15m in Series B funding.
The round was led by Fresenius Medical Care Ventures with participation from a second strategic investor, Red Cedar Ventures, and existing investor, the Pritzker-Vlock Family Office.
The company will use the funding to expand its commercial team and accelerate the development of its next-generation algorithms for guiding care for high-risk patients.